Literature DB >> 25767628

(18)F-FDG PET/CT for Detection of Metachronous Hodgkin's Disease in Patients with Myelofibrosis.

Thorsten Derlin1, Till Sebastian Clauditz2.   

Abstract

Entities:  

Year:  2014        PMID： 25767628      PMCID： PMC4354786          DOI： 10.1007/s13139-014-0307-z

Source DB:  PubMed          Journal:  Nucl Med Mol Imaging        ISSN： 1869-3474


× No keyword cloud information.
  11 in total

Review 1.  Pathogenesis of myelofibrosis with myeloid metaplasia.

Authors:  Ayalew Tefferi
Journal:  J Clin Oncol       Date:  2005-11-20       Impact factor: 44.544

2.  18F-FDG PET/CT for detection and localization of residual or recurrent disease in patients with multiple myeloma after stem cell transplantation.

Authors:  Thorsten Derlin; Christoph Weber; Christian R Habermann; Jochen Herrmann; Christian Wisotzki; Francis Ayuk; Christine Wolschke; Susanne Klutmann; Nicolaus Kröger
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-11-24       Impact factor: 9.236

3.  Primary chronic myelofibrosis: clinical and prognostic evaluation in 336 Japanese patients.

Authors:  T Okamura; N Kinukawa; Y Niho; H Mizoguchi
Journal:  Int J Hematol       Date:  2001-02       Impact factor: 2.490

4.  Reduced-intensity chemotherapy and PET-guided radiotherapy in patients with advanced stage Hodgkin's lymphoma (HD15 trial): a randomised, open-label, phase 3 non-inferiority trial.

Authors:  Andreas Engert; Heinz Haverkamp; Carsten Kobe; Jana Markova; Christoph Renner; Antony Ho; Josée Zijlstra; Zdenek Král; Michael Fuchs; Michael Hallek; Lothar Kanz; Hartmut Döhner; Bernd Dörken; Nicole Engel; Max Topp; Susanne Klutmann; Holger Amthauer; Andreas Bockisch; Regine Kluge; Clemens Kratochwil; Otmar Schober; Richard Greil; Reinhard Andreesen; Michael Kneba; Michael Pfreundschuh; Harald Stein; Hans Theodor Eich; Rolf-Peter Müller; Markus Dietlein; Peter Borchmann; Volker Diehl
Journal:  Lancet       Date:  2012-04-04       Impact factor: 79.321

Review 5.  Concomitant primary polycythemia vera and follicle center cell non-Hodgkin lymphoma: a case report and review of the literature.

Authors:  Rita Rizzi; Arcangelo Liso; Alessandra Pannunzio; Paola Carluccio; Giorgina Specchia; Vincenzo Liso
Journal:  Leuk Lymphoma       Date:  2002-11

6.  Leukemic transformation in myelofibrosis with myeloid metaplasia: a single-institution experience with 91 cases.

Authors:  Ruben A Mesa; Chin-Yang Li; Rhett P Ketterling; Georgene S Schroeder; Ryan A Knudson; Ayalew Tefferi
Journal:  Blood       Date:  2004-09-23       Impact factor: 22.113

7.  18F-FDG PET for diagnosis and response assessment for aggressive NK cell leukemia.

Authors:  Jeong A Park
Journal:  Clin Nucl Med       Date:  2014-04       Impact factor: 7.794

8.  Myelofibrosis with myeloid metaplasia: clinical and haematological parameters predicting survival in a series of 133 patients.

Authors:  G Visani; C Finelli; U Castelli; M C Petti; P Ricci; N Vianelli; L Gianni; E Zuffa; M A Aloe Spiriti; R Latagliata
Journal:  Br J Haematol       Date:  1990-05       Impact factor: 6.998

Review 9.  Choosing between stem cell therapy and drugs in myelofibrosis.

Authors:  N Kröger; R A Mesa
Journal:  Leukemia       Date:  2008-01-10       Impact factor: 11.528

10.  Conjunctival MALT lymphoma: utility of FDG PET/CT for diagnosis, staging, and evaluation of treatment response.

Authors:  Asmaa Sallak; Florent L Besson; Anastasia Pomoni; Alexandre Christinat; Marcel Adler; Jean-Philippe Aegerter; Christophe Nguyen; Laurence de Leval; Valérie Frossard; John O Prior
Journal:  Clin Nucl Med       Date:  2014-03       Impact factor: 7.794
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.